According to MannKind Corp's latest financial reports and stock price the company's current number of shares outstanding is 263,969,000. At the end of 2023 the company had 263,969,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.26 B | 0.22% |
2022 | 0.26 B | 4.9% |
2021 | 0.25 B | 7.04% |
2020 | 0.23 B | 13.49% |
2019 | 0.20 B | 34.57% |
2018 | 0.15 B | 31.9% |
2017 | 0.11 B | -75.66% |
2016 | 0.47 B | 14.09% |
2015 | 0.41 B | 5.68% |
2014 | 0.39 B | 17.64% |
2013 | 0.33 B | 47.14% |
2012 | 0.22 B | 87.35% |
2011 | 0.12 B | 7.78% |
2010 | 0.11 B | 4.37% |
2009 | 0.10 B | 7.02% |
2008 | 0.10 B | 38.26% |
2007 | 73.52 M | 47.84% |
2006 | 49.73 M | 14.43% |
2005 | 43.46 M | 54.93% |
2004 | 28.05 M | 70.36% |
2003 | 16.46 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | 5,634,000,000 | 2,034.34% | ๐บ๐ธ USA |
![]() Novo Nordisk NVO | 2,249,600,000 | 752.22% | ๐ฉ๐ฐ Denmark |
![]() Eli Lilly LLY | 949,267,000 | 259.61% | ๐บ๐ธ USA |
![]() Merck MRK | 2,538,000,000 | 861.48% | ๐บ๐ธ USA |
![]() Halozyme Therapeutics HALO | 135,027,000 | -48.85% | ๐บ๐ธ USA |
![]() Nektar Therapeutics
NKTR | 188,875,000 | -28.45% | ๐บ๐ธ USA |